ArticleCancer management and research2022

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.

Tian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.